List of Locus Pharmaceuticals patents | 5 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7741479 Urea inhibitors of MAP kinases	Patent 7741479 was granted and assigned to Locus Pharmaceuticals on June, 2010 by the United States Patent and Trademark Office.	‌ Locus Pharmaceuticals	United States Patent and Trademark Office	7741479	June 22, 2010
‌ US Patent 7504401 Anti-cancer agents and uses thereof	Patent 7504401 was granted and assigned to Locus Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.	‌ Locus Pharmaceuticals	United States Patent and Trademark Office	7504401	March 17, 2009
‌ US Patent 8962623 Aminopyrazine compounds	Patent 8962623 was granted and assigned to Locus Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.	‌ Locus Pharmaceuticals	United States Patent and Trademark Office	8962623	February 24, 2015
‌ US Patent 7612200 Inhibitors of protein kinases	Patent 7612200 was granted and assigned to Locus Pharmaceuticals on November, 2009 by the United States Patent and Trademark Office.	‌ Locus Pharmaceuticals	United States Patent and Trademark Office	7612200	November 3, 2009
‌ US Patent 7415361 Methods and systems for analyzing and determining ligand-residue interaction	Patent 7415361 was granted and assigned to Locus Pharmaceuticals on August, 2008 by the United States Patent and Trademark Office.	‌ Locus Pharmaceuticals	United States Patent and Trademark Office	7415361	August 19, 2008